Increased nitric oxide activity in early renovascular hypertension

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 270, Issue 1 39-1, 1996, Pages

  Dubey, Raghvendra K ^a   Boegehold, Matthew A ^b   Gillespie, Delbert G ^b   Rosselli, Marinella ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b NONE

Author keywords

guanosine 3',5' cyclic monophosphate; nitrite nitrate

Indexed keywords

CYCLIC GMP; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RENOVASCULAR HYPERTENSION;

EID: 0030029869     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1996.270.1.r118     Document Type: Article

References (31)

1. Arnal, J. F., T. Battle, J. Menard, and J. B. Michel. The vasodilatory effect of endogenous nitric oxide is a major counter-regulatory mechanism in the spontaneously hypertensive rat. J. Hypertens. 11: 945-950, 1993.
2. Arnal, J. F., L. Warin, and J. B. Michel. Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase. J. Clin. Invest. 90: 647-652, 1992.
3. G-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears impaired. J. Hypertens. 10: 1025-1031, 1992.
4. Dubey, R. K. Vasodilator-derived nitric oxide inhibits angiotensin-II- and fetal calf serum-induced growth of renal arteriolar smooth muscle cells. J. Pharmacol. Exp. Ther. 269: 402-408, 1994.
5. Dubey, R. K., E. K. Jackson, and T. F. Luscher. Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell: role of cyclic-nucleotides and angiotensin I receptors. J. Clin. Invent. 96: 141-149, 1995.
6. G-monomethyl-L-arginine in spontaneously hypertensive and normotensive Wistar-Kyoto rats. Br. J. Pharmacol. 102: 823-826, 1991.
7. Honma, M., T. Satoh, J. Takezawa, and M. Ui. An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samples from blood and tissue. Biochem. Med. 18: 257-273, 1977.
8. Jameson, M., F.-X. Dai, T. F. Luscher, J. Skopec, A. Diederich, and D. Diederich. Endothelium-derived contracting factors in resistance arteries of young spontaneously hypertensive rats before development of overt hypertension. Hypertension Dallas 21: 280-288, 1993.
9. Lais, L. T., L. L. Rios, S. Boutelle, G. F. DiBona, and M. J. Brody. Arterial pressure development in neonatal and young spontaneously hypertensive rats. Blood Vessels 14: 277-284, 1977.
10. Luscher, T. F., and R. K. Dubey. Endothelium and platelet-derived vasoactive substances: role in the regulation of vascular tone and growth. In: Hypertension: Pathophysiology, Diagnosis and Management (2nd ed.), edited by J. H. Laragh and B. M. Brenner. New York: Raven, 1995, p. 609-630.
11. Luscher, T. F., P. M. Vanhoutte, and L. Raij. Antihypertensive therapy normalizes endothelium-dependent relaxations in salt-induced hypertension of the rat. Hypertension Dallas 9, Suppl. III: III-193-III-197, 1987.
12. Marietta, M. A., P. S. Yoon, R. Lyengar, C. D. Leaf, and J. S. Wishnok. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 27: 8706-8711, 1988.
13. Mayhan, W. G. Impairment of endothelium-dependent dilation of basilar artery during chronic hypertension. Am. J. Physiol. 259 (Heart Circ. Physiol. 28): H1455-H1462, 1990.
14. Moncada, S., R. M. J. Palmer, and E. A. Higgs. NO: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43: 109-142, 1991.
15. Morris, S. M., and T. R. Billiar. New insights into the regulation of inducible nitric oxide synthesis. Am. J. Physiol. 266 (Endocrinol. Metab. 29): E829-E839, 1994.
16. G-monomethyl L-arginine on endothelium-dependent relaxation in arterioles of one-kidney, one-clip hypertensive rats. Hypertension Dallas 17: 875-880, 1991.
17. Nakayama, I., Y. Kawahara, T. Tsuda, M. Koide, Y. Ishida, and M. Yokoyama. Angiotensin inhibits cytokine-stimulated inducible nitric oxide synthase expression in vascular smooth muscle cells (Abstract). Hypertension Dallas 22: 414, 1993.
18. Otsuka, Y., A. Dipiero, E. Hirt, B. Brennaman, and W. Lockette. Vascular relaxation and cGMP in hypertension. Am. J. Physiol. 254 (Heart Circ. Physiol. 23): H163-H169, 1988.
19. Overbeck, H. W., and R. K. Dubey. Plasma-derived serum from hypertensive rats differentially increases growth of cul-tured arteriolar smooth muscle. Am. J. Physiol. 267 (Regulatory Integrative Comp. Physiol. 36): R489-R495, 1994.
20. Panza, J. A., P. R. Casino, C. M. Kilcoyne, and A. A. Quyyumi. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 87: 1468-1474, 1993
21. Papapetropoulos, A., N. Marczin, M. D. Snead, C. Cheng, A. Milici, and J. D. Catravas. Smooth muscle cell responsiveness to nitrovasodilators in hypertensive and normotensive rats. Hypertension Dallas 23: 476-484, 1994.
22. Pollock, D. M., J. S. Polakowski, B. J. Divish, and T. J. Opgenorth. Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition. Hypertension Dallas 21: 660-666, 1993.
23. Rosselli, M., B. Imthurn, E. Macas, P. J. Keller, and R. K. Dubey. Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17β-estradiol and norethisterone acetate: a two-year follow-up study. Hypertension Dallas 25: 848-853, 1995.
24. Rubanyi, G. M., J. C. Romero, and P. M. Vanhoutte. Flow-induced release of endothelium-derived relaxing factor Am. J. Physiol. 250 (Heart Circ. Physiol. 19): H1145-H1149, 1986.
25. Scott-Burden, T., V. B. Schini, E. Elizondo, J. C. Junquero, and P. M. Vanhoutte. Platelet derived growth factor suppresses and fibroblast growth factor enhances cytokine-induced production of NO by cultured aortic SMCs: effects on cell proliferation. Circ. Res. 71: 1088-1100, 1992
26. Shultz, P. J., and J. P. Tolins. Adaptation to increased dietary salt intake in the rat. Role of endogenous nitric oxide. J. Clin. Invest. 91: 642-650, 1993.
27. Sigmon, D. H., and W. H. Beierwaltes. Nitric oxide influences blood flow distribution in renovascular hypertension. Hypertension Dallas 23, Suppl. I: I-34-I-39, 1994.
28. Stacy, D. L., and R. L. Prewitt. Effects of chronic hypertension and its reversal on arteries and arterioles. Circ. Res. 65 869-879, 1989.
29. Tolins, J. R., R. M. J. Palmer, S. Moncada, and L. Raij. Role of endothelium-derived relaxing factor in regulation of renal hemodynamic responses. Am. J. Physiol. 258(Heart Circ. Physiol. 27): H655-H662, 1990.
30. Watt, P. A. C., and H. Thurston. Endothelium-dependent relaxation in resistance vessels from the spontaneously hypertensive rats. J. Hypertens. 7: 661-666, 1989.
31. Yang, S.-T., W. G. Mayhan, F. M. Faraci, and D. D. Heistad. Endothelium-dependent responses of cerebral blood vessels during chronic hypertension Hypertension Dallas 17: 612-618, 1991.